Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04208217
Other study ID # IIR 17-294
Secondary ID 12760065
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date July 22, 2021
Est. completion date September 30, 2025

Study information

Verified date February 2024
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evidence-based VA care is best for meeting Veterans' mental health needs, such as depression, PTSD and opioid use disorder, to prevent suicide or overdose. But some key evidence-based practices only reach 3-28% of patients. Participatory system dynamics (PSD) helps improve quality with existing resources, critical in mental health and all VA health care. PSD uses learning simulations to improve staff decisions, showing how goals for quality can best be achieved given local resources and constraints. This study aims to significantly increase the proportion of patients who start and complete evidence-based care, and determine the costs of using PSD for improvement. Empowering frontline staff with PSD simulation encourages safe 'virtual' prototyping of complex changes to scheduling, referrals and staffing, before translating changes to the 'real world.' This study determines if PSD increases Veteran access to the highest quality care, and if PSD better maximizes VA resources when compared against usual trial-and-error approaches to improving quality.


Description:

Background: Evidence-based practices (EBPs) are the most high value treatments to meet Veterans' addiction and mental health needs, reduce chronic impairment, and prevent suicide or overdose. Over 10 years, VA invested in dissemination of evidence-based psychotherapies and pharmacotherapies based on substantial evidence of effectiveness as compared to usual care. Quality metrics also track progress. Despite these investments, patients with prevalent needs, such as depression, PTSD and opioid use disorder often don't receive EBPs. Systems theory explains limited EBP reach as a system behavior emerging dynamically from local components (e.g., patient demand/health service supply). Participatory research and engagement principles guide participatory system dynamics (PSD), a mixed-methods approach used in business and engineering, shown to be effective for improving quality with existing resources. Significance/Impact: This study is proposed in the high priority area of VA addiction and mental health care to improve Veteran access to VA's highest quality care. The PSD program, Modeling to Learn (MTL), improves frontline management of dynamic complexity through simulations of staffing, scheduling and service referrals common in healthcare, across generalist and specialty programs, patient populations, and provider disciplines/treatments. Innovation: Recent synthesis of VA data in the enterprise-wide SQL Corporate Data Warehouse (CDW) makes it feasible to scale participatory simulation learning activities with VA frontline addiction and mental health staff. MTL is an advanced quality improvement (QI) infrastructure that helps VA take a major step toward becoming a learning health care system, by empowering local multidisciplinary staff to develop change strategies that fit to local capacities and constraints. Model parameters are from one VA source and generic across health services. If findings show that MTL is superior to usual VA quality improvement activities of data review with facilitators from VA program offices, this paradigm could prove useful across VA services. The PSD approach also advances implementation science. Systems theory explains how dynamic system behaviors (EBP reach) are defined by general scientific laws, yet arise from idiographic local conditions. Empowering staff with systems science simulation encourages the safe prototyping of ideas necessary for learning, increasing ongoing quality improvement capacities, and saving time and money as compared to trial-and-error approaches. Specific Aims: 1. Effectiveness: Test for superiority of MTL over usual QI for increasing the proportion of patients (1a) initiating, and (1b) completing a course of evidence-based psychotherapy (EBPsy) and evidence-based pharmacotherapy (EBPharm). 2. Scalable: (2a) Evaluate usual QI and MTL fidelity. (2b) Test MTL fidelity for convergent validity with participatory measures. (2c) Test the participatory theory of change: Evaluate whether 12 month period EBP reach is mediated by team scores on participatory measures. 3. Affordable: (3a) Determine the budget impact of MTL. (3b). Calculate the average marginal costs per 1% increase in EBP reach. Methodology: This study proposes a two-arm, 24-clinic (12 per arm) cluster randomized trial to test for superiority of MTL over usual QI for increasing EBP reach. Clinics will be from 24 regional health care systems (HCS) below the SAIL mental health median, and low on 3 of 8 SAIL measures associated with EBPs. Computer-assisted stratified block randomization will balance MTL and usual QI arms at baseline using Corporate Data Warehouse (CDW) data. Participants will be the multidisciplinary frontline teams of addiction and mental health providers. Next Steps/Implementation: MTL was developed in partnership with the VA Office of Mental Health and Suicide Prevention (OMHSP) and if shown to be effective, scalable, and affordable for improving timely Veteran access to EBPs, MTL will be scaled nationally to more clinics by expanding MTL online resources, and training more VA staff to facilitate MTL activities instead of usual QI.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 720
Est. completion date September 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 24 health care systems currently functioning below the median VA mental health recommendations for Strategic Analytics for Improvement & Learning (SAIL) and below the median for 3 of 8 SAIL evidence-based treatment approaches. - VA divisions and community-based outpatient clinics (CBOCs) or 'clinics' from regional VA health systems - Must be below the overall VA quality median (as assessed by the Strategic Analytics for Improvement and Learning or SAIL), which includes 3 of 8 SAIL measures associated with four evidence-based psychotherapies and three evidence-based pharmacotherapies for depression, PTSD, and opioid use disorder. Exclusion Criteria: Health care systems functioning above median VA mental health recommendations for Strategic Analytics for Improvement & Learning (SAIL) and below the median for 3 of 8 SAIL evidence-based treatment approaches. Only one health care system can be included per arm - MTL vs QI. - clinics with less than 12 months of data in 2018 - clinics involved in Office of Veterans Access to Care (OVACS) quality improvement program at baseline - clinics where the VA Cerner electronic health record (EHR) implementation rollout will occur during the project period (Veterans Integrated Services Networks (VISNs) 20, 21 ,22, and 7) - clinics who serve less than 122 unique patients each month on average - clinics without an onsite multidisciplinary team of mental health or addiction service providers (minimum required: 1 psychiatrist, 1 psychologist, 1 social worker onsite)

Study Design


Intervention

Behavioral:
Modeling to Learn (MTL)
Modeling to Learn is a facilitated health care quality improvement or evidence-based practice implementation strategy that includes frontline addiction and mental health staff running simulations of clinic improvement strategies to find the best approaches for improving the reach of evidence-based psychotherapy and evidence-based pharmacotherapy.
Usual quality improvement (QI)
Usual quality improvement is a health care quality improvement or evidence-based practice implementation strategy that includes frontline addiction and mental health staff reviewing data to find the best approaches for improving the reach of evidence-based psychotherapy and evidence-based pharmacotherapy.

Locations

Country Name City State
United States VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of patients initiating and completing a course of evidence-based psychotherapy (EBPsy) or evidence-based pharmacotherapy (EBPharm) Proportion evidence-based practice (EBP) reach is defined as the proportion of VA outpatient addiction and mental health patients who receive evidence-based psychotherapy and/or evidence-based pharmacotherapy for opioid use disorder, depression, or PTSD in routine outpatient VA care. Pre-/Post- 12-month period average of EBP reach (24 months total observation)]
Primary Number of completed EBPsy templates during sessions with a relevant CPT code Proportion of 3 EBPsy treatments for depression - Cognitive Behavior Therapy (CBT-D), Acceptance and Commitment Therapy (ACT), Interpersonal Psychotherapy (IPT) 2 EBPsy for PTSD - Prolonged Exposure (PE), and Cognitive Processing Therapy (CPT) Pre-/Post- 12-month period average of EBP reach (24 months total observation)]
Primary Number of combination of prescriptions placed with the VA pharmacy and sessions with a relevant CPT code Proportion of 2 EBPharm treatments for depression - 84 and 180 days therapeutic continuity at new antidepressant start and 2 EBPharm for Opioid Use Disorder (OUD) - methadone and buprenorphine Pre-/Post- 12-month period average of EBP reach (24 months total observation)]
Secondary Differences in team perceptions of MTL and QI assessed by the Acceptability of Intervention Measure (AIM) Assesses differences in team perceptions of MTL and QI using the 4 item survey 'Acceptability of Intervention Measure (AIM)'.
Scale: 1-5, in 1 point increments (1 = completely disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = completely agree)
at 6 months
Secondary Differences in team perceptions of MTL and QI assessed by the Intervention Appropriateness Measure (IAM) Assesses differences in team perceptions of MTL and QI using the 4 item survey 'Intervention Appropriateness Measure (IAM)'.
Scale: 1-5, in 1 point increments (1 = completely disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = completely agree)
at 6 months
Secondary Differences in team perceptions of MTL and QI assessed by the Feasibility of Intervention Measure (FIM) Assesses differences in team perceptions of MTL and QI using the 4 item survey 'Feasibility of Intervention Measure (FIM)'.
Scale: 1-5, in 1 point increments (1 = completely disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = completely agree)
at 6 months
Secondary Patient Aligned Care Team Burnout Measure (PACT) Quality of work satisfaction and burnout in a 4-item descriptive measure from VA team-based primary care that tracks 1) years of experience with the team, 2) working on more than one team, 3) turnover/change in team staff, 4) team overwork, and the single-item 5) self-reported burnout (sensitivity 83.2% and specificity 87.4%).
Higher turnover numbers and high reported levels of burn out are considered negative.
At baseline and 6 months
Secondary Participatory Measure: Context Assesses differences in MTL and QI decision context Scale: 1-5 (1 = VA Central Office, 2 = VA Facility Leadership, 3 = Clinic Managers, 4 = Our team, 5 = Individual providers on our team) At baseline and 6 months
Secondary Participatory Measure: Partnership Structural Values Assess differences in MTL and QI partnership structural values in a 22-item measure with subscales a) partner focus, b) core values, c) participation, d) cooperation, e) respect, and f) trust
Subscale a) partner focus Scale: 1-5, in 1 point increments (1 = not at all , 5 = to a great extent) Alpha = 0.82
Subscale b-f) core values, participation, cooperation, respect, trust) Scale: 1-5, in 1 point increments (1 = strongly disagree, 5 = strongly agree) Subscale b) Alpha = 0.89 Subscale c) Alpha = 0.78 Subscale d) Alpha = 0.83 Subscale e) Alpha = 0.83 Subscale f) Alpha = 0.86
At 6 months
Secondary Participatory Measure: Relationships Assess differences in MTL and QI relationships in a 15-item measure with subscales a) participatory decision-making, b) leadership, and c) use of resources
Subscale a) participatory decision-making Scale: 1-5, in 1 point increments (1 = never, 5 = always) Alpha = 0.83
Subscale b) leadership Scale: 1-5, in 1 point increments (1 = very ineffective, 5 = very effective) Alpha = 0.94
Subscale c) use of resources Scale: 1-5, in 1 point increments (1 = makes poor use, 5 = makes excellent use) Alpha = n/a
At 6 months
Secondary Participatory Measure: Synergy Assess differences in MTL and QI synergy in a 5-item measure.
Scale: 1-5, in 1 point increments (1 = not at all, 5 = to a great extent) Alpha = 0.90
At 6 months
Secondary Participatory Measure: Capacity-Building Index Assess differences in MTL and QI capacity-building index in a 5-item measure
Scale: 1-5, in 1 point increments (1 = Not at all, 2 = Very Little, 3 = Somewhat, 4 = To a Large Extent, 5 = To a Very Great Extent) Alpha = 0.90
At 6 months
Secondary Facilitator Quality: Engagement Principles 10-item engagement principles measure that assesses investigator readiness to conduct participatory implementation science research. Assesses team and co-facilitator self-ratings of co-facilitators' use of engagement principles, such as building trusting relationships, knowledge of local conditions, and support for existing local capacities
Scale: 1-5, in 1 point increments (1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree)
Response options range from 1 (strongly disagree) to 5 (strongly agree). Items will be summed for analyses, and the investigators will evaluate for convergence/divergence across facilitator and team ratings
At 6 months
Secondary MTL Fidelity Checklist for 12-Session Plan Track MTL arm fidelity to 12-Session plan resources, sessions, online outputs, and standardized weekly emails Throughout 6 months
Secondary QI Fidelity Checklist for 12-Session Plan Track QI arm fidelity to 12-Session plan resources, sessions, online outputs, and standardized weekly emails Throughout 6 months
Secondary Quality Improvement Activity Tracking Tracking form adapted from a current VA operations-focused, implementation facilitation trial by the VA Team-Based Behavioral Health QUERI Program with four strengths specific to our study of: 1) assessment of activity costs readily comparable to other another VA multisite trial, 2) measure from Behavioral Health Interdisciplinary Program (BHIP) Enhancement Project, team-focused MH care, like PSD, 3) emphasis on quantifying a) staff and b) facilitator time, rather than categorizing content, 4) prior use in VA. Throughout 6 months
Secondary Demographic Measures 4 item measure assessing ethnic (Hispanic, Latino, Latina, or Latinx), racial (American Indian/Alaska Native, Asian, Native Hawaiian or Other Pacific Islander, Black or African American, White, More than One Race) and gender (Man, Woman, Non-binary) identity of respondent.
All items include a "Prefer not to say" option. Categories for demographic measures determined based on NIH reporting standards.
At baseline and 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A